The up‐regulation of RIG‐I and its innate activation contribute to endogenous IL‐23 production, subsequently driving immune responses leading to initiation of psoriasis in susceptible individuals, indicating that RIG‐I is probably a critical trigger rather than a regulator in remission. The gene discussed is IL23A; the disease is psoriasis.